Dr Thomas Erblich

Dr Thomas Erblich is a fully qualified Consultant Haematologist at Queen Elizabeth Hospital, London, where he runs a general haematology clinic, and supervises the care of patients on the chemotherapy unit 

While his practice encompasses the full breadth of general haematology, he has a particular expertise in haemato-oncology and lymphoma. He serves as the named consultant for lymphoma and is a Principal Investigator for haematology clinical trials.

Dr Erblich graduated from the Medical University of Vienna in 2006. He completed specialist training in haematology at St Bartholomew's Hospital, London, and was awarded his Certificate of Completion of Training in 2019. He completed a clinical research fellowship in haemato-oncology at Barts Cancer Institute, Queen Mary University of London, focusing on lymphoma research. In 2024, he was awarded a PhD for his research into lymphoma and non-invasive diagnostic approaches using circulating tumour DNA.

Alongside his clinical practice, Dr Erblich remains actively involved in research into blood cancers and their treatment. He has published in peer-reviewed medical journals and presented his work at national and international scientific meetings. He is a member of the National Lymphoma Network Scientific Subgroup and contributes to national guideline development through the British Society for Haematology.

Dr Erblich sees patients with a wide range of haematological conditions, including abnormal blood counts, lymph node enlargement, iron disorders, MGUS, lymphoma, leukaemia, myeloma and other blood diseases. His practice emphasises timely diagnosis, clear communication and personalised care tailored to each individual's circumstances and priorities.

Consultations are available for newly diagnosed patients, individuals seeking a second opinion and those requiring ongoing monitoring or treatment.

Depending on the underlying condition, treatment may involve intravenous iron therapy, blood transfusion, venesection, chemotherapy, immunotherapy or targeted therapies.

Dr Erblich is experienced in performing bone marrow aspiration and trephine biopsy. He is fully trained and accredited in procedural sedation, ensuring that these procedures are performed with particular attention to patient comfort, dignity and safety.

When more complex investigation or treatment is required, Dr Erblich works closely with specialist nurses, pathologists, radiologists, oncologists and fellow haematologists to ensure every aspect of a patient's case is carefully considered. Established links with specialist centres allow seamless referral for advanced treatments, including stem cell transplantation and CAR T-cell therapy, when appropriate.